ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 150 filers reported holding ZIOPHARM ONCOLOGY INC in Q1 2022. The put-call ratio across all filers is 0.02 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $3,000 | -40.0% | 5,000 | 0.0% | 0.00% | -100.0% |
| Q4 2021 | $5,000 | -44.4% | 5,000 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $9,000 | -30.8% | 5,000 | 0.0% | 0.00% | -50.0% |
| Q2 2021 | $13,000 | -27.8% | 5,000 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $18,000 | +38.5% | 5,000 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $13,000 | 0.0% | 5,000 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $13,000 | -18.8% | 5,000 | 0.0% | 0.00% | -33.3% |
| Q2 2020 | $16,000 | +33.3% | 5,000 | 0.0% | 0.00% | +50.0% |
| Q1 2020 | $12,000 | -50.0% | 5,000 | 0.0% | 0.00% | -50.0% |
| Q4 2019 | $24,000 | +14.3% | 5,000 | 0.0% | 0.00% | +33.3% |
| Q3 2019 | $21,000 | -27.6% | 5,000 | 0.0% | 0.00% | -40.0% |
| Q2 2019 | $29,000 | +52.6% | 5,000 | 0.0% | 0.01% | +25.0% |
| Q1 2019 | $19,000 | +111.1% | 5,000 | 0.0% | 0.00% | +100.0% |
| Q4 2018 | $9,000 | – | 5,000 | +6072.8% | 0.00% | – |
| Q1 2018 | $0 | – | 81 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Belmont Global Advisors, Inc. | 2,564,925 | $11,132,000 | 8.99% |
| Essex Woodlands Management, Inc. | 2,764,908 | $11,330,000 | 5.70% |
| Third Security, LLC | 17,815,708 | $77,320,000 | 3.68% |
| MSD Partners, L.P. | 2,750,000 | $11,935,000 | 0.49% |
| SFMG, LLC | 99,850 | $433,000 | 0.15% |
| GM Advisory Group, LLC | 12,500 | $54,000 | 0.06% |
| Geduld E E | 25,000 | $109,000 | 0.05% |
| WESTPORT RESOURCES MANAGEMENT INC | 30,500 | $132,000 | 0.04% |
| Janney Montgomery Scott LLC | 335,571 | $1,456,378,000 | 0.04% |
| WFG Advisors, LP | 48,040 | $208,000 | 0.03% |